Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma

Update Il y a 5 ans
Reference: NCT00422786

Woman and Man

  • | Country :
  • France
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study was to evaluate the safety and efficacy of CAP-232 in the treatment of patients with previously treated (refractory) renal cell carcinoma


Inclusion criteria

  • Carcinoma, Renal Cell

Links